Sign in
8-K

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001558370-16-008451

Material agreement · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading cerc-20160922x8k.htm…